Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  allogeneic CD3- CD19- selected natural killer cells
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Donor Natural Killer Cell Infusion and ALT-803 in Treating Patients with Refractory or Relapsed Acute Myeloid Leukemia
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 to 70
Trial IDs: 2016LS056, NCI-2017-01043, NCT03050216
Start Over